General Information of Drug (ID: DMS325C)

Drug Name
6-fluoropyridin-3-ylboronic acid Drug Info
Synonyms
351019-18-6; 2-Fluoropyridine-5-boronic acid; 2-Fluoro-5-pyridylboronic acid; (6-fluoropyridin-3-yl)boronic Acid; 6-fluoropyridine-3-boronic acid; 2-fluoro-5-pyridineboronic acid; 2-fluoropyridin-5-ylboronic acid; 6-fluoropyridin-3-ylboronic acid; 2-fluoropyridin-5-boronic acid; 6-Fluoro-3-pyridinylboronic acid; 6-Fluoro-3-pyridylboronic Acid; 6-fluoropyridin-3-yl-3-boronic acid; 6-FLUORO-3-PYRIDINEBORONIC ACID; (6-fluoropyridin-3-yl)boranediol; BORONIC ACID, (6-FLUORO-3-PYRIDINYL)-; (6-fluoro-3-pyridyl)boronic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
2783397
CAS Number
CAS 351019-18-6
TTD Drug ID
DMS325C

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid amide hydrolase (FAAH) TTDP1UC NOUNIPROTAC Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Fatty acid amide hydrolase (FAAH) DTT FAAH 5.744 5.044 4.818 5.984
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Fatty acid amide hydrolase (FAAH) DTT NO-GeName 2.65E-01 0.02 0.1
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Nov 27;51(22):7057-60.